At Freyr One USA 2026, the session ‘Delivering enterprise regulatory intelligence at scale’ examined a practical question: when regulatory change affects severa…
At Freyr One USA 2026, a panel of industry leaders including Boris Reznichenko (Otsuka), Ryan McNeely (Gilead Sciences), Lauren Orme (West Pharmaceutical Servic…
At Freyr One USA 2026, industry leaders including Jack Cohen (Takeda), Andrew Robertson (Denali Therapeutics), and Sathya K (Freyr Solutions) came together for …
Cleaning validation is a critical component of pharmaceutical quality systems, ensuring that manufacturing equipment is free of residues that could compromise p…
Clinical Trial Application submissions across global markets, covering regulatory documentation, CMC considerations, and submission requirements.
Clinical trial monitoring supports patient safety, data integrity, and regulatory compliance throughout clinical development and trial execution.
Company Core Data Sheet management supports consistent safety and efficacy information across global pharmaceutical markets and product labels.
UAE pharmaceutical regulatory transformation covering digitalization, regulatory innovation, and emerging developments shaping the sector.
Malaysia drug registration requirements covering six key steps for preparing a compliant NPRA submission dossier.
Philippines drug registration covering the regulatory pathway, submissions, evaluation, labeling, renewals, and compliance requirements.
This blog talks about integrating QMS and data security to strengthen medical device quality assurance.
Global regulatory submissions across 120+ countries, supporting life sciences companies with regulatory management and global market access.
Cosmetic ingredient compliance requirements can vary significantly across global markets. An accepted ingredient in one market may be restricted or banned in an…
EMA Module 1 regulatory changes from 2024, covering updated guideline expectations and key content requirements for regulatory submissions.
This blog talks about GACC registration in China under Decree 280, covering food manufacturers, exporters, renewal, CIFER and import requirements.
SaMD regulatory strategy covering classification, regulatory pathways, evidence requirements, lifecycle considerations, and global market planning.
India mandatory eCTD submissions: CDSCO requirements, implementation considerations, and preparation priorities for pharmaceutical manufacturers in 2026.
Indonesian halal regulations covering regulatory requirements, manufacturer concerns, and compliance preparedness for the local market.
Japan ICH guidelines for generics taking effect in April 2026, covering harmonization, quality expectations, and regulatory preparation.
Japan PMDA eCTD best practices for 2026 submissions, covering dossier preparation, compliance requirements, and submission readiness.